Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

COPING With COVID-19( CWC-19)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04343690
Recruitment Status : Withdrawn (Study Ended May 1, 2020 with no enrollment)
First Posted : April 13, 2020
Last Update Posted : September 23, 2020
Sponsor:
Information provided by (Responsible Party):
Duke University

Brief Summary:
The purpose of this study is 1) to understand effects of COVID-19 crisis on wellness of pulmonary and critical care faculty and trainees who are at frontline fighting this pandemic 2) Assess the effectiveness of series of weekly web based crisis management coaching from world renowned experts in coaching and 3) identify future areas of opportunities in physician wellness

Condition or disease Intervention/treatment Phase
COVID-19 Behavioral: Crisis management coaching Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 0 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Other
Official Title: Effectiveness of Crisis Management Coaching on Faculty and Trainee Wellness During COVID-19 Crisis
Actual Study Start Date : March 27, 2020
Actual Primary Completion Date : May 1, 2020
Actual Study Completion Date : May 1, 2020

Arm Intervention/treatment
Experimental: Health Care Workers
Faculty, staff, and trainees dealing with COVID-19 pandemic
Behavioral: Crisis management coaching
Crisis management coaching will be offered to faculty, staff, and trainees dealing with COVID-19 pandemic




Primary Outcome Measures :
  1. Change in stress level as measured by survey [ Time Frame: Baseline, mid-session (up to 4 weeks), post-intervention (up to 8 weeks) ]

Secondary Outcome Measures :
  1. Change wellness as measured by survey [ Time Frame: Baseline, mid-session (up to 4 weeks), post-intervention (up to 8 weeks) ]
    Survey is 14-items asking about wellness on a scale from "Strongly Agree" to "Not at all"



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Any faculty, staff, or trainee from Duke pulmonary and critical care that consents to being in the study

Exclusion Criteria:

-


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04343690


Locations
Layout table for location information
United States, North Carolina
Duke University
Durham, North Carolina, United States, 27710
Sponsors and Collaborators
Duke University
Investigators
Layout table for investigator information
Principal Investigator: Patty Lee, MD Duke University
Principal Investigator: Sangeeta Joshi, MD Duke University
Layout table for additonal information
Responsible Party: Duke University
ClinicalTrials.gov Identifier: NCT04343690    
Other Study ID Numbers: Pro00105319
First Posted: April 13, 2020    Key Record Dates
Last Update Posted: September 23, 2020
Last Verified: April 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No